Kevin Kinsella
-
FDA to consider relaxing restrictions for peptides
The regulator said it is looking to take seven peptides off a restrictive list for unapproved drugs considered too risky.
-
Fake it ’til you make it: Study finds nearly half of health-related AI responses ‘problematic’
Researchers are concerned by the confident tone generative AI models use in their responses, considering their lack of credentials.
-
Podiatrist, pharma rep sentenced to 63 months for healthcare fraud
In a case involving an unlicensed person performing medical procedures on unwitting patients, the two California men billed state and federal programs $3.2m in false claims.
-
FDA targets companies marketing unapproved weight‑loss drugs online
The FDA’s latest round of warning letters points to an intensifying regulatory trend targeting companies marketing and selling GLP-1 and related compounds online.
-
War with Iran hits global pharma and medical supply chain
The on-again, off-again closure of the Strait of Hormuz, the ongoing US war with Iran, and restrictions in air travel are having an impact on global pharmaceutical and medical supply chains.
-
CMS issues final 2027 Medicare Advantage and Part D Payment Rates
Payor and provider groups are saying the rate increases may not be enough to stave off cuts to coverage.
-
More than 80% of physicians use AI regularly
A survey from the American Medical Association found more than three‑quarters of physicians say AI improves their ability to care for patients, citing diagnostic accuracy and work efficiency as top benefits.
-
HHS unleashes AI strategy plan
Announced in early December 2025, the strategy marks the most comprehensive federal effort to date to govern AI across the health sector, and it arrives at a pivotal moment.